Loading live market data…

Gracell Biotechnologies Inc.

NASDAQ:GRCL

$10.25 USD

$0.01 (0.05%)

Volume
6.37M
Average Volume
1.61M
Market Capitalization
$197.97M
P/E Ratio
-1.55
Dividend Yield
0.00%
Price Target
$6.00
Year High
$10.44
Year Low
$1.40
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$6.78
Source Headline

Get GRCL Insider Trade Alerts

GRCL Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$0.00

0 analysts

All Time

$6.00

1 analysts

GRCL Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2024-02-22 Stifel Downgrade Buy Hold
2023-12-27 Wells Fargo Downgrade Overweight Equal Weight
2023-12-27 Piper Sandler Downgrade Overweight Neutral
2023-12-26 BTIG Downgrade Buy Neutral
2023-12-26 HC Wainwright & Co. Downgrade Buy Neutral
2023-09-05 Cantor Fitzgerald Maintain Overweight Overweight
2023-09-04 Cantor Fitzgerald Maintain Overweight Overweight
2023-08-30 Cantor Fitzgerald Maintain Overweight Overweight
2023-08-29 Cantor Fitzgerald Maintain Overweight Overweight
2023-08-29 Citigroup Maintain Buy Buy
2023-08-28 Citigroup Maintain Buy Buy
2023-08-14 HC Wainwright & Co. Maintain Buy Buy
2023-08-13 HC Wainwright & Co. Maintain Buy Buy
2023-06-13 BTIG Maintain Buy Buy
2023-06-12 BTIG Maintain Buy Buy
2023-05-26 HC Wainwright & Co. Maintain Buy Buy
2023-05-25 HC Wainwright & Co. Maintain Buy Buy
2023-02-16 HC Wainwright & Co. Maintain Buy Buy
2023-02-06 HC Wainwright & Co. Maintain Buy Buy
2022-12-08 HC Wainwright & Co. Maintain Buy Buy
2022-09-22 Citigroup Maintain Buy Buy
2022-06-01 Cantor Fitzgerald Maintain Overweight Overweight
2022-04-04 BTIG Maintain Buy Buy
2021-02-03 Citigroup Maintain Buy Buy
2021-02-02 Wells Fargo Maintain Overweight Overweight
2021-02-02 Piper Sandler Maintain Overweight Overweight
2021-02-02 Jefferies Maintain Buy Buy